HealthBaby HealthBaby

AutoXpress® System (AXP®)

AutoXpress® System (AXP®)
 
  • Produced by U.S. Cesca Therapeutics (Netcord official partner), FDA cleared and highly compatible with BioArchive®
  • The only automated processing system specially designed for stem cells harvesting
  • Automated closed system, individual sterile processing to avoid sample mix-up
  • Most used automated cord blood processing system in both Asia and U.S. regions. Among all automated system processing cord blood samples, over 75% samples are processed by AXP®31
  • The highest Mononuclear cell (MNC) - 98.7% and Total nucleated cell (TNC) - 96.2% recoveries in the industry, 18% higher than other systems16
  • MNC content will be used instead of TNC:
    • As an indicator of cord blood unit quality
    • Criteria of selecting sample for transplant27
  • XpressTRAK™ software compatible with international ISBT barcode for global information tracking

 

MNC & TNC Recovery Rate28
MNC TNC

 

HealthBaby Consultant
 

Maximizing the Stem Cells Extraction

AutoXpress® (AXP®) Platform is the mostly adopted cord blood processing system (including New York Blood Centre and the largest Cord Blood Registry of U.S.). The system can collect 98.7 stem cells per 100 stem cells. Since the success of transplantation is determined by the quantity and viability of stem cells, HealthBaby therefore adopts the AXP® to maximize the extract of stem cells.

The claim of other processing system® ability to extract 99.46% TNC lacks of objectivity since the data is only from the cord blood bank's own experiment but not an objective third party. But according to the third parties, The American Congress of Obstetricians and Gynecologists and the largest Cord Blood Registry of U.S., other processing system® can only extract 80.3% of TNC but not 99.46%. Beware and do not be misled. In addition, only MNC but not TNC should be the criteria of transplant sample standard27.

HealthBaby Consultant

 

AutoXpress® - Maximizing the Stem Cells Extraction

 

AXP® System

Other System
Specificity
  • FDA(USA), CE(Europe) and CSA(Canada) cleared. The highest quality standards including FACT and AABB attained
  • The latest automated sterile processing system, specifically designed for stem cells harvesting
  • Seamless compatibility with BioArchive® System ensuring long-term storage of the maximum number of stem cells
  • Not specific for umbilical cord blood processing
Stem Cells Retrieval Rate
  • Consistently retrieves 98.7% MNC and 96.2% TNC, audited by U.S. Obstetrics & Gynaecology Society and Cord Blood Registry(The Largest Cord Blood Bank in U.S.)sup>16
  • Retrieves only 79.9% MNC and 80.3% TNC, audited by U.S. Obstetrics & Gynaecology Society and Cord Blood Registry(The Largest Cord Blood Bank in U.S.)16 (please be aware of the exaggerated data >99%, provided by other cord blood banks)
Operation
  • Closed independent processing system, eradicating contamination
  • Automated processing in 45 minutes. Suitable for cord blood banks with high capacity
  • High sensitivity
  • XpressTRAK™ software provides real time and accurate data processing
  • Compatible with ISBT barcode for global information tracking
  • Over 65 minutes processing time, only for cord blood banks with low capacity
  • Prolonged processing time will delay the processing of other cord blood samples and stem cells viability will be affected
Global Usage
  • Most used automated cord blood processing system in both Asia and US regions
  • Most used by the largest cord blood bank, including New York Blood Center and Cord Blood Registry(The Largest Cord Blood Bank in U.S.)
  • Most users shifted to use AXP® to enhance stem cells retrieval rateclarify
  • Official collaborator of NETCORD organization
  • Processed over 750,000 cord blood samplesclarify
  • Over 40 countries
Recall Problem
  • In response to the AXP® recall in 2008, this was due to the raw materials problems of the bagset manufacturing, not related to safety issue and AXP® operation. However, the "Plan for Voluntary Recall" was highly appreciated by FDA, which the action was not a forcible recall20,21